New drug Kylo-12 tested in humans for first time to lower high fats in blood
NCT ID NCT06783881
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 27 times
Summary
This early-stage study tests a new drug called Kylo-12 in 50 healthy volunteers with high triglycerides (a type of fat in the blood). The main goal is to check safety and how the drug moves through the body. Researchers will also look at how it affects fat levels. This is a first step to see if Kylo-12 might help control high triglycerides in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chengdu Xinhua Hospital
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.